The Enterprise Value as of December 2025 (TTM) for RemeGen Co., Ltd. (9995.HK) is 44.47B

According to RemeGen Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 44.47B. This represents a change of 24.97% compared to the average of 35.58B of the last 4 quarters.

RemeGen Co., Ltd. (9995.HK) Historical Enterprise Value (quarterly & annually)

How has 9995.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of RemeGen Co., Ltd. over the last ten years is 23.38B. The current 44.47B Enterprise Value has changed 18.92% with respect to the historical average. Over the past ten years (40 quarters), 9995.HK's Enterprise Value was at its highest in in the September 2025 quarter at 66.78B. The Enterprise Value was at its lowest in in the March 2019 quarter at 0.

RemeGen Co., Ltd. (9995.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of RemeGen Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

RemeGen Co., Ltd. (9995.HK) Average Enterprise Value

How has 9995.HK Enterprise Value performed in the past?

The current Enterprise Value of RemeGen Co., Ltd. (9995.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

RemeGen Co., Ltd. (9995.HK) Enterprise Value vs. Peers

How is 9995.HK’s Enterprise Value compared to its peers?

RemeGen Co., Ltd.’s Enterprise Value is greater than Shanghai Junshi Biosciences Co., Ltd. (35.56B), greater than Genscript Biotech Corporation (3.91B), less than Pharmaron Beijing Co., Ltd. (48.17B), greater than Shanghai Henlius Biotech, Inc. (32.76B), greater than XtalPi Holdings Ltd (36.27B), greater than Hangzhou Tigermed Consulting Co., Ltd. (38.00B), greater than Ascentage Pharma Group International (18.53B), less than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (49.15B), greater than Simcere Pharmaceutical Group Limited (27.31B), greater than Asymchem Laboratories (Tianjin) Co., Ltd. (25.58B),

Build a custom stock screener for RemeGen Co., Ltd. (9995.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RemeGen Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RemeGen Co., Ltd. (9995.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RemeGen Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.